Perfromance Wealth Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Perfromance Wealth Partners’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,000	Closed	-$5.89K	–	195
2024 Q4	$5.89K	Hold	11,000	–	–	﹤0.01%	185
2024 Q3	$19.4K	Buy	+11,000	New	+$15.4K	﹤0.01%	196

Perfromance Wealth Partners's MRNS Position: Q1 2025 in Review

Perfromance Wealth Partners sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 11,000 shares — an estimated $5.89K sold.

Perfromance Wealth Partners first reported a position in MRNS in Q3 2024 and held it in 2 quarters. The position peaked at $19.4K in Q3 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Perfromance Wealth Partners reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Perfromance Wealth Partners sold 11,000 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $5.89K.
Perfromance Wealth Partners first reported a position in Marinus Pharmaceuticals, Inc in Q3 2024 and held it in 2 quarters.
Perfromance Wealth Partners's Marinus Pharmaceuticals, Inc position peaked at $19.4K in Q3 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Perfromance Wealth Partners's 13F filing for Q1 2025, filed 22 Apr 2025.